Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07589543
Recruiting
Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer
Phase 1/2 · China · 1 site
Registry update: 15 May 2026
NCT07615426
Recruiting
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Phase 1 · United States · 8 sites
Registry update: 3 Nov 2026
2025-521819-39-00
Recruiting
TADalafil in early-stage Parkinson’s Disease (TAD-PD)
Phase 2 · Netherlands · 1 site
Registry update: 5 Jan 2026
NCT07453602
Recruiting
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Phase 1 · United States · 7 sites
Registry update: 23 Oct 2026
NCT07502287
Recruiting
Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
Phase 1/2 · China · 1 site
Registry update: 30 Mar 2026
NCT07528066
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
Not applicable · China, France, Italy · 10 sites
Registry update: 14 Apr 2026
NCT07551336
Recruiting
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · China · 1 site
Registry update: 24 Apr 2026
NCT07148947
Recruiting
Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms
Phase 2 · United States · 1 site
Registry update: 19 Aug 2026
NCT07463846
Recruiting
A Study to Evaluate ALN-2232 in Participants With Obesity
Phase 1/2 · Canada · 1 site
Registry update: 13 Oct 2026
NCT07617805
Recruiting
EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC
Phase 1/2 · China · 1 site
Registry update: 1 Jun 2026
NCT07209254
Recruiting
Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
Not applicable · United States · 3 sites
Registry update: 22 May 2026
NCT07448623
Recruiting
A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis.
Phase 1 · Netherlands · 1 site
Registry update: 13 Apr 2026
NCT07374848
Recruiting
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Phase 1 · China, United States · 8 sites
Registry update: 23 Jul 2026
NCT07434050
Recruiting
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
Phase 3 · China · 1 site
Registry update: 28 Aug 2026
NCT07523555
Recruiting
Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies
Phase 1/2 · China · 1 site
Registry update: 13 Apr 2026
NCT07641023
Recruiting
Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC
Phase 1/2 · China · 1 site
Registry update: 11 Jun 2026
NCT07438964
Recruiting
Non-invasive Brain Stimulation in Multiple Sclerosis Fatigue
Not applicable · Germany · 1 site
Registry update: 27 Feb 2026
NCT07413757
Recruiting
CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC
Not applicable · China · 1 site
Registry update: 9 Oct 2026
NCT07641036
Recruiting
Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer
Phase 1/2 · China · 1 site
Registry update: 11 Jun 2026
NCT07319676
Recruiting
Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas
Phase 1/2 · Singapore · 1 site
Registry update: 9 Apr 2026

Ordered by registry start date. Freshness and sponsorship never change the order.